These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 31378329)

  • 21. Restoring normal sinus rhythm in atrial fibrillation : evidence from pharmacologic therapy and catheter ablation trials.
    Zimetbaum P
    Curr Cardiol Rep; 2006 Sep; 8(5):377-86. PubMed ID: 17153280
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pilsicainide for conversion and maintenance of sinus rhythm in chronic atrial fibrillation: a placebo-controlled, multicenter study.
    Okishige K; Nishizaki M; Azegami K; Igawa M; Yamawaki N; Aonuma K;
    Am Heart J; 2000 Sep; 140(3):e13. PubMed ID: 10966544
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of postprocedural antiarrhythmic drug therapy with bepridil on maintaining sinus rhythm after catheter ablation for persistent atrial fibrillation.
    Kondo T; Miake J; Kato M; Ogura K; Iitsuka K; Yamamoto K
    J Cardiol; 2016 Sep; 68(3):229-35. PubMed ID: 26654806
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Time to cardioversion of recurrent atrial arrhythmias after catheter ablation of atrial fibrillation and long-term clinical outcome.
    Baman TS; Gupta SK; Billakanty SR; Ilg KJ; Good E; Crawford T; Jongnarangsin K; Ebinger M; Pelosi F; Bogun F; Chugh A; Morady F; Oral H
    J Cardiovasc Electrophysiol; 2009 Dec; 20(12):1321-5. PubMed ID: 19602031
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Atrial fibrillation: the rate versus rhythm management controversy.
    Camm AJ; Savelieva I
    J R Coll Physicians Edinb; 2012; 42 Suppl 18():23-34. PubMed ID: 22518391
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Non-pharmacologic management of atrial fibrillation.
    Brenyo AJ; Aktas MK
    Am J Cardiol; 2011 Jul; 108(2):317-25. PubMed ID: 21545986
    [TBL] [Abstract][Full Text] [Related]  

  • 27. What can rhythm control therapy contribute to prognosis in atrial fibrillation?
    Rolf S; Kornej J; Dagres N; Hindricks G
    Heart; 2015 Jun; 101(11):842-6. PubMed ID: 25792720
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rate versus rhythm control in patients with atrial fibrillation: what the trials really say.
    Crijns HJ
    Drugs; 2005; 65(12):1651-67. PubMed ID: 16060699
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Management of atrial fibrillation: therapeutic options and clinical decisions.
    Prystowsky EN
    Am J Cardiol; 2000 May; 85(10A):3D-11D. PubMed ID: 10822035
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effectiveness of rhythm control in persistent or permanent atrial fibrillation with overdrive atrial pacing and antiarrhythmic drugs after linear right atrial catheter ablation.
    Filipecki A; Saksena S; Lin WH
    Am J Cardiol; 2003 Nov; 92(9):1037-44. PubMed ID: 14583353
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rate Versus Rhythm Control for Atrial Fibrillation.
    Halsey C; Chugh A
    Heart Fail Clin; 2016 Apr; 12(2):193-203. PubMed ID: 26968665
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Newer developments in the management of atrial fibrillation.
    Nattel S
    Am Heart J; 1995 Nov; 130(5):1094-106. PubMed ID: 7484742
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Strategies for managing atrial fibrillation.
    Katcher MS; Foote CB; Homoud M; Wang PJ; Estes NA
    Cleve Clin J Med; 1996 Sep; 63(5):282-94. PubMed ID: 8870339
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ablation of atrial arrhythmias in heart failure.
    Aagaard P; Di Biase L; Natale A
    Heart Fail Clin; 2015 Apr; 11(2):305-17. PubMed ID: 25834977
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New and emerging antiarrhythmic and anticoagulant agents for atrial fibrillation.
    Cheng JW
    Am J Health Syst Pharm; 2010 May; 67(9 Suppl 5):S26-34. PubMed ID: 20410533
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New concepts in atrial defibrillation.
    Ayers GM
    J Interv Card Electrophysiol; 2000 Jan; 4 Suppl 1():155-61. PubMed ID: 10590503
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of an aggressive rhythm control strategy on sinus rhythm maintenance following intra-operative radiofrequency ablation of atrial fibrillation in patients undergoing surgical correction of valvular disease.
    Sponga S; Leoni L; Buja G; Nalli C; Voisine P; Gerosa G
    J Cardiol; 2012 Oct; 60(4):316-20. PubMed ID: 22898332
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiarrhythmic Drug Therapy for Atrial Fibrillation.
    Sardar MR; Saeed W; Kowey PR
    Heart Fail Clin; 2016 Apr; 12(2):205-21. PubMed ID: 26968666
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Cardiac rhythm management of patients with atrial fibrillation].
    Tréguer F
    Rev Prat; 2020 Oct; 70(8):915-920. PubMed ID: 33739701
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Case studies with the experts: management decisions in atrial fibrillation.
    Prystowsky EN; Jaïs P; Kowey P; Nattel S; Ruskin JN
    J Cardiovasc Electrophysiol; 2008 Feb; 19 Suppl 1():S1-12; quiz S13-5. PubMed ID: 18226097
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.